Immunocore Holdings $402.5 million convertible notes offering
The 2.5% convertible notes are due 2030
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Immatics $201 million follow-on offering
We advised Immatics on the offering of shares
IDEAYA Biosciences $350 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Alector $75 million stock offering
The common stock is listed on the Nasdaq Global Select Market
OPKO Health $230 million convertible senior notes offering
The 3.75% convertible notes are due 2029
Auna $550 million secured term loan refinancing
We advised Auna on the transaction
Solid Biosciences $109 million private placement
The PIPE includes common stock and pre-funded warrants
Olema Pharmaceuticals $150 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
HighTide Therapeutics HK$194.1 million IPO
We advised HighTide Therapeutics on its IPO and HKEX listing
Auna exchange offer and consent solicitations
We advised the Auna on the transaction